Exploring the Role of Glycosylation Inhibitors in Lymphoma and Drug Therapy
Objective: Lymphoma, impacting individuals across all age groups with a preference for younger males, presents challenges in drug target selectivity. Mucin glycosylation is being investigated as a potential cellular barrier in the treatment of lymphoma. This review explores glycosylation inhibitors as potential enhancers of therapeutic agents for lymphoma treatment.
Authors
- Robert W. Campbell (ORCID: https://orcid.org/0000-0002-7112-4292)
- Thao Nguyen (ORCID: https://orcid.org/0000-0003-4261-576X)
- Shayan Mosaffa
- Nasr Issa
Institutions
- Massachusetts College of Pharmacy and Health Sciences (US)
Publication Details
- Journal
- American Journal of Pharmaceutical Education
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.ajpe.2024.101215
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00